SARAH BARTLETT: Open Payments
NPI 1750945234 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 68 payments from 23 companies in 2025. Trend: 2023 $3,524 · 2024 $4,483 · 2025 $2,373
Food & beverage: $2,318Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $492 |
| Dendreon Pharmaceuticals LLC | 14 | $435 |
| Boston Scientific Corporation | 4 | $426 |
| Sumitomo Pharma America, Inc. | 8 | $180 |
| PFIZER INC. | 6 | $151 |
| Merck Sharp & Dohme LLC | 4 | $90 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $70 |
| SEAGEN INC. | 1 | $55 |
| AstraZeneca Pharmaceuticals LP | 1 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
Products named: PROVENGE, ERLEADA, Axonics, XTANDI, General - Male SUI, LYNPARZA, GEMTESA, ORGOVYX.
Industry payments across NC — which companies pay providers there.
